G-protein coupled receptor (gpcr) peptide ligand library
Ended Purchase Order Awarded
- Contract number
- 75N95020P00428
- Awardee
-
Phoenix Pharmaceuticals, Inc. UEI P8XLC937AAK3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,784
Award facts
- Opportunity
-
- 75N95020Q00234 Solicitation number
- Contract value 100% obligated
- $23,784.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Hillsborough, CA 94010, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95020P00428?
75N95020P00428 was awarded to Phoenix Pharmaceuticals, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 12, 2020.
How much is contract 75N95020P00428 worth?
The government has obligated $23,784 on 75N95020P00428.
Which agency awarded contract 75N95020P00428?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00428, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95020P00428 competed?
The extent of competition for 75N95020P00428 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award